Karen Lynn Roberts - Net Worth and Insider Trading

Karen Lynn Roberts Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karen Lynn Roberts owns 1 companies in total, including Dare Bioscience Inc (DARE) .

Click here to see the complete history of Karen Lynn Roberts’s form 4 insider trades.

Insider Ownership Summary of Karen Lynn Roberts

Ticker Comapny Transaction Date Type of Owner
DARE Dare Bioscience Inc 2014-04-10 Sr VP Finance & Administrat

Karen Lynn Roberts Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karen Lynn Roberts Ownership Network

Ownership Network List of Karen Lynn Roberts

No Data

Ownership Network Relation of Karen Lynn Roberts

Insider Network Chart

Karen Lynn Roberts Owned Company Details

What does Dare Bioscience Inc do?

Who are the key executives at Dare Bioscience Inc?

Karen Lynn Roberts is the Sr VP Finance & Administrat of Dare Bioscience Inc. Other key executives at Dare Bioscience Inc include director & Chef Executive Officer Sabrina Martucci Johnson , Chief Strategy Officer John A Fair , and Chief Financial Officer Lisa Walters-hoffert .

Dare Bioscience Inc (DARE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dare Bioscience Inc Insider Transactions

No Available Data

Karen Lynn Roberts Mailing Address

Above is the net worth, insider trading, and ownership report for Karen Lynn Roberts. You might contact Karen Lynn Roberts via mailing address: Cerulean Pharma Inc., 840 Memorial Drive, 5th Floor, Cambridge Ma 02139.

Discussions on Karen Lynn Roberts

No discussions yet.